A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib
Clinical trial NCT05924152 · COMPLETED
Trial details
- NCT number
- NCT05924152
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2023-08-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.